{{Rsnum
|rsid=1386330
|Chromosome=11
|position=88086259
|Orientation=plus
|GMAF=0.1148
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 19.5 | 79.6
| HCB | 0.0 | 12.4 | 87.6
| JPT | 0.0 | 13.5 | 86.5
| YRI | 1.4 | 15.6 | 83.0
| ASW | 0.0 | 12.3 | 87.7
| CHB | 0.0 | 12.4 | 87.6
| CHD | 1.8 | 15.6 | 82.6
| GIH | 3.0 | 30.7 | 66.3
| LWK | 0.9 | 14.5 | 84.5
| MEX | 5.2 | 50.0 | 44.8
| MKK | 1.3 | 24.4 | 74.4
| TSI | 2.9 | 22.5 | 74.5
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000002
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs1386330
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 11q14.2; Reported Gene(s): RAB38; Risk Allele: rs1386330-?); (p-value= 0.000002).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740721
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1386330
|overall_frequency_n=13
|overall_frequency_d=128
|overall_frequency=0.101562
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}